Education
About Us
Working with TipRanks
Follow Us
LGHT - AI Analysis
Top Page
Langar Global HealthTech ETF (LGHT)
Rating:70Neutral
Price Target:
$11.50
Positive Factors
Strong Mid-Tier Holdings
Several mid-weight holdings, such as Veeva Systems and Insulet, have delivered strong year-to-date performance, supporting the fund’s returns.
Focused Sector Exposure
The ETF’s concentration in the health care sector allows investors to target a high-growth industry with significant innovation potential.
Steady Asset Base
The ETF has maintained a reasonable level of assets under management, indicating consistent investor interest.
Negative Factors
High Expense Ratio
The ETF charges a relatively high expense ratio, which can eat into investor returns over time.
Underperforming Top Holdings
Some of the largest positions, like Intuitive Surgical and Dexcom, have seen weak year-to-date performance, dragging on the fund’s overall results.
Geographic Concentration
With over 95% exposure to U.S. companies, the ETF lacks geographic diversification, making it vulnerable to domestic market risks.
LGHT vs. SPDR S&P 500 ETF (SPY)
AUM4.28M
RegionGlobal
Expense Ratio0.85%
Beta0.92
IssuerLangar
Inception DateJan 10, 2024
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume540
30 Day Avg. Volume1,488
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
12.07Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering31
LGHT Summary
The Langar Global HealthTech ETF (LGHT) is an investment fund focused on healthcare technology, including digital health solutions, telemedicine, biotechnology, and medical devices. It features companies like Intuitive Surgical and Siemens Healthineers, which are leaders in medical innovation. This ETF is ideal for investors seeking long-term growth and diversification in the rapidly evolving healthcare sector. However, new investors should be aware that its performance is closely tied to the healthcare industry, which can be affected by regulatory changes and market fluctuations.
How much will it cost me?The Langar Global HealthTech ETF (LGHT) has an expense ratio of 0.85%, meaning you’ll pay $8.50 per year for every $1,000 invested. This is higher than average because it is actively managed, focusing on specialized healthcare technology companies rather than tracking a broad index.
What would affect this ETF?The Langar Global HealthTech ETF could benefit from growing demand for innovative healthcare solutions, such as telemedicine and advanced medical devices, driven by aging populations and technological advancements. However, it may face challenges from regulatory changes in healthcare, fluctuating global economic conditions, and potential competition within the health tech sector. Its global exposure and focus on leading companies like Intuitive Surgical and Siemens Healthineers position it well for long-term growth but also make it sensitive to international market volatility.
LGHT Top 10 Holdings
The Langar Global HealthTech ETF is heavily concentrated in healthcare technology, with standout performers like Veeva Systems and IQVIA Holdings driving gains thanks to strong profitability and strategic advancements in AI and innovation. ResMed and Insulet also contribute positively, buoyed by robust revenue growth and market expansion. However, lagging stocks like Dexcom and Sonova Holding are holding the fund back, with bearish momentum and valuation concerns weighing on performance. With a global mix of holdings, this ETF offers exposure to cutting-edge healthcare innovation but faces mixed results from its diverse portfolio.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Intuitive Surgical | 15.28% | $649.80K | $187.89B | 5.20% | 78 Outperform | |
| Siemens Healthineers AG Unsponsored ADR | 10.43% | $443.68K | $62.87B | 8.18% | 79 Outperform | |
| Veeva Systems | 8.20% | $348.88K | $46.72B | 36.49% | 81 Outperform | |
| Resmed | 7.67% | $326.17K | $36.82B | 4.04% | 71 Outperform | |
| IQVIA Holdings | 6.49% | $276.00K | $36.86B | 5.17% | 77 Outperform | |
| Insulet | 5.99% | $254.86K | $21.96B | 34.73% | 71 Outperform | |
| Dexcom | 5.72% | $243.34K | $26.74B | -3.23% | 71 Outperform | |
| GE Healthcare Technologies Inc | 4.55% | $193.35K | $34.16B | -14.14% | 74 Outperform | |
| Koninklijke Philips | 4.23% | $180.06K | $26.09B | 4.08% | 55 Neutral | |
| Sonova Holding AG | 4.17% | $177.51K | $15.77B | -24.85% | 73 Outperform |
LGHT Technical Analysis
Positive
―
Price Trends
10.25
Positive
10.28
Positive
10.25
Positive
Market Momentum
0.09
Negative
52.69
Neutral
51.63
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For LGHT, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 10.31, equal to the 50-day MA of 10.25, and equal to the 200-day MA of 10.25, indicating a bullish trend. The MACD of 0.09 indicates Negative momentum. The RSI at 52.69 is Neutral, neither overbought nor oversold. The STOCH value of 51.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for LGHT.
LGHT Peer Comparison
Comparison Results
Performance Comparison
LGHT
Langar Global HealthTech ETF
10.38
0.16
1.57%
CANC
Tema Oncology ETF
―
―
―
FMED
Fidelity Disruptive Medicine ETF
―
―
―
HRTS
Tema Cardiovascular and Metabolic ETF
―
―
―
OZEM
Roundhill GLP-1 & Weight Loss ETF
―
―
―
GDOC
Goldman Sachs Future Health Care Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents